Clinical Trials Insight: 700051726

Trial Profile

Clinical Trials Insight: 700051726

Phase of Trial: Phase I/II

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Registrational; Therapeutic Use
  • Sponsors Nippon Shinyaku
  • Most Recent Events

    • 21 Jan 2011 Azacitidine has been approved for treatment of myelodysplastic syndromes based on results of this and other trials.
    • 16 Dec 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top